论文部分内容阅读
目的探讨喜炎平注射液治疗婴幼儿秋季腹泻的疗效和临床安全性。方法选取2010年1月～2011年1月到我院就诊的500例婴幼儿秋季腹泻患儿为研究对象,随机分为实验组和对照组,对照组行病毒唑注射液治疗,实验组行喜炎平注射液治疗,回顾观察两组患儿的疗效和安全性。结果实验组临床治疗效果显著优于对照组,且各项临床指标的恢复情况显著优于对照组,两组患儿的临床疗效及安全性比较具有显著的统计学差异(P<0.05)。结论喜炎平注射液治疗婴幼儿秋季腹泻,具有较为理想的临床疗效,且治疗的安全性更好,不良反应发生率低,因而临床应用价值更高。
Objective To investigate the efficacy and clinical safety of Xiyanping injection in treating infantile autumn diarrhea. Methods From January 2010 to January 2011, 500 infants and young children with diarrhea infants admitted to our hospital were selected as study subjects and randomly divided into experimental group and control group. Ribavirin injection was given to the control group, Yan Ping injection treatment, review the efficacy and safety of two groups of children. Results The clinical efficacy of the experimental group was significantly better than that of the control group, and the recovery of various clinical indexes was significantly better than that of the control group. The clinical efficacy and safety of the two groups were significantly different (P <0.05). Conclusion Xiyanping injection for the treatment of infantile autumnal diarrhea has an ideal clinical efficacy, and the treatment of better safety, adverse reactions, low incidence, and thus clinical application of higher value.